Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some important caveats, provide reasonable value for money spent.
from The Medical News http://ift.tt/1D4mR1l
from The Medical News http://ift.tt/1D4mR1l
No comments:
Post a Comment